Showing 1 - 20 results of 41 for search 'R. Preston', query time: 0.05s
Refine Results
-
1
-
2
Cache and Carry: lithic technology and Mesolithic mobility by Paul R. Preston
Published 2009-09-01
Article -
3
TRANSPARENCIA Y POLÍTICAS ANTIMONOPÓLICAS by R. Preston McAfee
Published 2010-01-01
Article -
4
Right heart catheterisation: best practice and pitfalls in pulmonary hypertension by Stephan Rosenkranz, Ioana R. Preston
Published 2015-12-01
Article -
5
-
6
Safety and tolerability of bosentan in the management of pulmonary arterial hypertension by Kari E Roberts, Ioana R Preston
Published 2009-03-01
Article -
7
Is there a role for omega-3 fatty acids in cardiovascular disease risk reduction? by R.Preston Mason, Robert H. Eckel
Published 2021-09-01
Article -
8
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension by M Kathryn Steiner, Ioana R Preston
Published 2008-10-01
Article -
9
-
10
New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension by Ioana R. Preston, Samy Suissa, Marc Humbert
Published 2013-12-01
Article -
11
-
12
A Platform for Cognitive Monitoring of Neurosurgical Patients During Hospitalization by Omer Ashmaig, Omer Ashmaig, Liberty S. Hamilton, Liberty S. Hamilton, Liberty S. Hamilton, Pradeep Modur, Robert J. Buchanan, Robert J. Buchanan, Robert J. Buchanan, Robert J. Buchanan, Alison R. Preston, Alison R. Preston, Alison R. Preston, Alison R. Preston, Andrew J. Watrous, Andrew J. Watrous, Andrew J. Watrous, Andrew J. Watrous, Andrew J. Watrous
Published 2021-11-01
Article -
13
Practical management of riociguat in patients with pulmonary arterial hypertension by Michael Halank, Kristin Tausche, Ekkehard Grünig, Ralf Ewert, Ioana R. Preston
Published 2019-08-01
Article -
14
Knowledge of Social Affiliations Biases Economic Decisions. by Joel E Martinez, Michael L Mack, Bernard D Gelman, Alison R Preston
Published 2016-01-01
Article -
15
-
16
-
17
Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution by Samuel C.R. Sherratt, Peter Libby, Hazem Dawoud, Deepak L. Bhatt, Tadeusz Malinski, R. Preston Mason
Published 2023-06-01
Article -
18
-
19
-
20
Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor by Richard J. Cenedella, Robert Jacob, Douglas Borchman, Daxin Tang, Amanda R. Neely, Abbas Samadi, R. Preston Mason, Patricia Sexton
Published 2004-07-01
Article